Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Sarcolemmal KATP channel modulators and cardiac arrhythmias.

Baczkó I, Husti Z, Lang V, Leprán I, Light PE.

Curr Med Chem. 2011;18(24):3640-61. Review.

PMID:
21774762
2.

Intracellular signalling mechanism responsible for modulation of sarcolemmal ATP-sensitive potassium channels by nitric oxide in ventricular cardiomyocytes.

Zhang DM, Chai Y, Erickson JR, Brown JH, Bers DM, Lin YF.

J Physiol. 2014 Mar 1;592(5):971-90. doi: 10.1113/jphysiol.2013.264697. Epub 2013 Nov 25.

3.

ATP-sensitive potassium channel modulators and cardiac arrhythmias: an update.

Muntean DM, Kiss L, Jost N, Baczko I.

Curr Pharm Des. 2015;21(8):1091-102. Review.

PMID:
25354183
4.

The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy.

Billman GE.

Pharmacol Ther. 2008 Oct;120(1):54-70. doi: 10.1016/j.pharmthera.2008.07.004. Epub 2008 Jul 26. Review.

PMID:
18708091
5.

Role of sarcolemmal ATP-sensitive potassium channel in oxidative stress-induced apoptosis: mitochondrial connection.

Marinovic J, Ljubkovic M, Stadnicka A, Bosnjak ZJ, Bienengraeber M.

Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1317-25. doi: 10.1152/ajpheart.00840.2007. Epub 2008 Jan 11.

6.

Role of ATP-sensitive K+ channels in cardiac arrhythmias.

Nakaya H.

J Cardiovasc Pharmacol Ther. 2014 May;19(3):237-43. doi: 10.1177/1074248413515078. Epub 2013 Dec 23. Review.

PMID:
24367007
7.

Both mitochondrial KATP channel opening and sarcolemmal KATP channel blockage confer protection against ischemia/reperfusion-induced arrhythmia in anesthetized male rats.

Gonca E, Bozdogan O.

J Cardiovasc Pharmacol Ther. 2010 Dec;15(4):403-11. doi: 10.1177/1074248410372925. Epub 2010 Aug 5.

PMID:
20693159
8.

PKC-permitted elevation of sarcolemmal KATP concentration may explain female-specific resistance to myocardial infarction.

Edwards AG, Rees ML, Gioscia RA, Zachman DK, Lynch JM, Browder JC, Chicco AJ, Moore RL.

J Physiol. 2009 Dec 1;587(Pt 23):5723-37. doi: 10.1113/jphysiol.2009.181040. Epub 2009 Oct 5.

9.

Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection.

Sato T, Costa AD, Saito T, Ogura T, Ishida H, Garlid KD, Nakaya H.

J Pharmacol Exp Ther. 2006 Jan;316(1):182-8. Epub 2005 Sep 20.

10.

Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.

Driamov S, Bellahcene M, Ziegler A, Barbosa V, Traub D, Butz S, Buser PT, Zaugg CE.

Basic Res Cardiol. 2004 Jul;99(4):299-308. Epub 2004 Mar 2.

PMID:
15221348
11.

Effects of the blockade of cardiac sarcolemmal ATP-sensitive potassium channels on arrhythmias and coronary flow in ischemia-reperfusion model in isolated rat hearts.

Gok S, Vural K, Sekuri C, Onur R, Tezcan A, Izanli A.

Vascul Pharmacol. 2006 Apr;44(4):197-205. Epub 2006 Feb 21.

PMID:
16495160
12.

Remodeling of atrial ATP-sensitive K⁺ channels in a model of salt-induced elevated blood pressure.

Lader JM, Vasquez C, Bao L, Maass K, Qu J, Kefalogianni E, Fishman GI, Coetzee WA, Morley GE.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H964-74. doi: 10.1152/ajpheart.00410.2011. Epub 2011 Jul 1.

14.

5-Hydroxydecanoate and coenzyme A are inhibitors of native sarcolemmal KATP channels in inside-out patches.

Li X, Rapedius M, Baukrowitz T, Liu GX, Srivastava DK, Daut J, Hanley PJ.

Biochim Biophys Acta. 2010 Mar;1800(3):385-91. doi: 10.1016/j.bbagen.2009.11.012. Epub 2009 Nov 18.

PMID:
19931596
15.
17.

Unique properties of the ATP-sensitive K⁺ channel in the mouse ventricular cardiac conduction system.

Bao L, Kefaloyianni E, Lader J, Hong M, Morley G, Fishman GI, Sobie EA, Coetzee WA.

Circ Arrhythm Electrophysiol. 2011 Dec;4(6):926-35. doi: 10.1161/CIRCEP.111.964643. Epub 2011 Oct 9.

18.

Phenylephrine preconditioning involves modulation of cardiac sarcolemmal K(ATP) current by PKC delta, AMPK and p38 MAPK.

Turrell HE, Rodrigo GC, Norman RI, Dickens M, Standen NB.

J Mol Cell Cardiol. 2011 Sep;51(3):370-80. doi: 10.1016/j.yjmcc.2011.06.015. Epub 2011 Jun 26.

PMID:
21740910
19.

Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts.

Quindry JC, Schreiber L, Hosick P, Wrieden J, Irwin JM, Hoyt E.

Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H175-83. doi: 10.1152/ajpheart.01211.2009. Epub 2010 Apr 30.

20.

Early opening of sarcolemmal ATP-sensitive potassium channels is not a key step in PKC-mediated cardioprotection.

Brennan S, Jackson R, Patel M, Sims MW, Hudman D, Norman RI, Lodwick D, Rainbow RD.

J Mol Cell Cardiol. 2015 Feb;79:42-53. doi: 10.1016/j.yjmcc.2014.10.016. Epub 2014 Nov 6.

PMID:
25450614

Supplemental Content

Support Center